ST

Seth-Olov Thorberg

AC Astra Co.: 16 patents #3 of 446Top 1%
AA Astrazeneca Ab: 15 patents #39 of 1,971Top 2%
AA Astra Lakemedel Aktiebolag: 3 patents #8 of 84Top 10%
📍 Haditha, IQ: #1 of 23 inventorsTop 5%
Overall (All Time): #103,982 of 4,157,543Top 3%
34
Patents All Time

Issued Patents All Time

Showing 1–25 of 34 patents

Patent #TitleCo-InventorsDate
7439356 Substituted indan derivatives Stefan Berg, Lennart Florvall, Svante Ross 2008-10-21
7384943 Substituted chroman derivatives Stefan Berg, Martin Nylof, Svante Ross 2008-06-10
7056921 Substituted chroman derivatives Stefan Berg, Martin Nylof, Svante Ross 2006-06-06
6670359 Substituted chroman derivatives Stefan Berg, Martin Nylof, Svante Ross 2003-12-30
6548498 Substituted indan derivatives Stefan Berg, Lennart Florvall, Svante Ross 2003-04-15
6534652 Intermediates for the preparation of substituted 1,2,3,4-tetrahydronaphthalene derivatives Stefan Berg, Svante Ross 2003-03-18
6479497 Substituted chroman derivatives Stefan Berg, Martin Nylof, Svante Ross 2002-11-12
6472423 Pharmaceutical composition Svante Ross 2002-10-29
6410532 Substituted 1,2,3,4-tetrahydronaphthalene derivatives Stefan Berg, Mats Linderberg, Svante Ross, Bengt Ulff 2002-06-25
6410530 Substituted 1,2,3,4-tetrahydronaphthalene derivatives Stefan Berg, Lennart Florvall, Svante Ross 2002-06-25
6387899 Substituted chroman derivatives Stefan Berg, Mats Linderberg, Svante Ross, Bengt Ulff 2002-05-14
6384225 Intermediates in the preparation of substituted chroman derivatives Stefan Berg, Mats Linderberg, Svante Ross, Bengt Ulff 2002-05-07
6313118 Substituted 1,2,3,4-tetrahydronaphthalene derivatives Stefan Berg, Mats Linderberg, Svante Ross, Bengt Ulff 2001-11-06
6184219 Composition and methods employing it for the treatment of 5-HT-mediated disorders John Evenden 2001-02-06
6184218 Composition and methods employing it for the treatment of 5-HT-mediated disorders John Evenden 2001-02-06
6172105 Composition and methods employing it for the treatment of 5-HT-mediated disorders John Evenden 2001-01-09
6169098 Composition and methods employing it for the treatment of 5-HT-mediated disorders John Evenden 2001-01-02
6159971 Combination of a 5-HT reuptake inhibitor and a H5-HT1B anatagonist or partial agonist Stefan Berg, Svante Ross 2000-12-12
6159970 Combination of a monoamine oxidase inhibitor and a h5-HT.sub.1B antagonist or partial agonist Stefan Berg, Svante Ross 2000-12-12
6159972 Combination of a selective 5-HT.sub.1A antagonist and a selective ub . h5-HT.s1B antagonist or partial agonist Stefan Berg, Svante Ross 2000-12-12
6124283 Substituted 1,2,3,4-tetrahydronaphthalene derivatives Stefan Berg, Lennart Florvall, Svante Ross 2000-09-26
5962514 Combination of 5-HT uptake inhibitor with a selective 5-HT1A antagonist John Evenden 1999-10-05
5656657 Chroman derivatives Eva Maria Hammarberg, Lars George Johansson, Lars-Gunnar Larsson, Rolf Noreen, Lucy Anna Renyi +3 more 1997-08-12
5656658 Method for the treatment of anxiety Eva Maria Hammarberg, Lars George Johansson, Lars-Gunnar Larsson, Rolf Noreen, Lucy Anna Renyi +3 more 1997-08-12
5646309 Intermediates in the synthesis of chroman derivatives Eva Maria Hammarberg, Lars George Johansson, Lars-Gunnar Larsson, Rolf Noreen, Lucy Anna Renyi +3 more 1997-07-08